Filing Details

Accession Number:
0001209191-20-035185
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-09 07:27:45
Reporting Period:
2020-06-08
Accepted Time:
2020-06-09 07:27:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681682 Endra Life Sciences Inc. NDRA () CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1083544 Anthony Digiandomenico C/O Endra Life Sciences Inc.
3600 Green Court, Suite 350
Ann Arbor MI 48105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-08 5,000 $0.92 281,509 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.90 to $0.94, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. Includes unvested restricted stock units.